Protection against myxomatosis and rabbit viral hemorrhagic disease with recombinant myxoma viruses expressing rabbit hemorrhagic disease virus capsid protein [PDF]
, 1995 Two myxoma virus-rabbit hemorrhagic disease virus (RHDV) recombinant viruses were constructed with the SG33 strain of myxoma virus to protect rabbits against myxomatosis and rabbit viral hemorrhagic disease.
Bertagnoli, Stéphane +9 more
core +2 more sources
Global progress, challenges and strategies in eliminating public threat of viral hepatitis
Infectious Diseases of PovertyBackground The problem caused by viral hepatitis is a major public health challenge faced in the past decade, and the global goal of eliminating viral hepatitis by 2030 is still far away.
Sihui Zhang, Fuqiang Cui
doaj +1 more source
Revista Brasileira de Hematologia e Hemoterapia, 2012 OBJECTIVE: To evaluate viral vaccine antibody levels in children with acute lymphoblastic leukemia after chemotherapy and after vaccine booster doses.
Simone Santana Viana +5 more
doaj +1 more source
Eliminating Viral Hepatitis from India and Southeast Asia by 2030: Challenges and Ways Forward
Preventive Medicine: Research & ReviewsThis review was conducted to understand the epidemiology of hepatitis in Southeast Asia, examine the current scenario, and suggest a way forward for elimination. A comprehensive desk review was followed by analysis and interpretation.
Senthilkumar Ramasamy +5 more
doaj +1 more source
Current progress in the development of therapeutic vaccines for chronic hepatitis B virus infection [PDF]
Iranian Journal of Basic Medical Sciences, 2016 Chronic hepatitis B is still a major public health issue despite the successful prophylactic vaccination attempts. Chronicity of hepatitis B virus(HBV) is mainly due to its ability to debilitate host's immune system.
Faezeh Ghasemi +3 more
doaj
Plant-based vaccines against viral hepatitis: A panoptic review
World Journal of VirologyThe traditional vaccines against hepatitis have been instrumental in reducing the incidence of some types of viral hepatitis; however, the need for cost-effective, easily distributable, and needle-free vaccine alternatives has led to the exploration of plant-based vaccines.
Reka, Devanathan +1 more
openaire +2 more sources
Inhibition of adenovirus serotype 14 infection by octadecyloxyethyl esters of (S)-[(3-hydroxy-2-phosphonomethoxy)propyl]- nucleosides in vitro. [PDF]
, 2018 On September 22, 2008, a physician on Prince of Wales Island, Alaska, notified the Alaska Department of Health and Social Services (ADHSS) of an unusually high number of adult patients with recently diagnosed pneumonia (n = 10), including three persons ...
Barnard, Dale L +8 more
core
Redefining the immune landscape of hepatitis A virus infection
Experimental and Molecular MedicineDespite the development of effective vaccines against hepatitis A virus (HAV) infection, outbreaks of acute hepatitis A still occur globally, such that HAV remains a major cause of acute viral hepatitis.
Ombretta Colasanti +3 more
doaj +1 more source
JHEP ReportsBackground & Aims: Liver diseases resulting from chronic HBV infection are a significant cause of morbidity and mortality. Vaccines that elicit T-cell responses capable of controlling the virus represent a treatment strategy with potential for long ...
Anna H. Mooney +22 more
doaj +1 more source
Therapeutic Opportunities in Infectious Diseases: Highlights from the Society of Medicines Research Symposium, held on March 14th 2013 at the National Heart & Lung Institute, London, UK [PDF]
, 2013 Alderton, W K +3 more
core +1 more source